For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Gi Innovation, Inc.

USPTO Granted Patents = 10

EPO Patents = 5

Forward Citations = 4

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Myung Ho Jang (7 out of 10 patents)

Young Jun Koh (4 out of 13 patents)

Su Youn Nam (3 out of 7 patents)

4. Myoung Ho Jang (3 out of 5 patents)

5. Zungyoon Yang (2 out of 4 patents)

6. Young Chul Sung (2 out of 25 patents)

7. Young-Gyu Cho (1 out of 5 patents)

8. Bo-Gie Yang (1 out of 1 patent)

9. Kyungwha Lee (1 out of 1 patent)

10. Dan Bee Ha (1 out of 1 patent)

11. Heonchang Lim (0 patent)

12. Soontak Kwon (0 patent)

13. Young Min Oh (0 patent)

10 patents: Sort by Forward Citations

1. 12478675 - PHARMACEUTICAL COMPOSITION FOR ENHANCING RADIOTHERAPY COMPRISING FUSION PROTEIN CONTAINING IL-2 PROTEIN AND CD80 PROTEIN (2025-11-25),

2. 12414984 - Fusion protein comprising anti-CD73 antibody and IL-2, and use thereof (2025-09-16),

3. 12410233 - Extracellular domain of alpha subunit of IgE Fc receptor, pharmaceutical composition comprising same and method for producing same (2025-09-09),

4. 12409203 - Polypeptide dimer with high sialic acid content, comprising extracellular domain of alpha subunit of IGE FC receptor, and pharmaceutical composition comprising same (2025-09-09),

5. 12291555 - Fusion protein comprising IL-2 protein and CD80 protein, and use thereof (2025-05-06),

6. 12286464 - Fusion protein comprising IL-2 protein and CD80 protein, and use thereof (2025-04-29),

7. 12128076 - Composition comprising probiotics and polypeptide having binding affinity for IgE and use thereof (2024-10-29),

8. 11857601 - Pharmaceutical composition for cancer treatment comprising fusion protein including IL-2 protein and CD80 protein and anticancer drug (2024-01-02),

9. 11639383 - Pharmaceutical composition for treatment of cancer, comprising an immune checkpoint inhibitor antibody and a fusion protein comprising an IL-2 mutant and a CD80 extracellular domain (2023-05-02),

10. 11492384 - Fusion protein comprising IL-2 protein and CD80 protein, and use thereof (2022-11-08),

Gi Innovation, Inc. is a technology-centric company focused on developing innovative solutions that enhance operational efficiency and streamline processes across various industries. With a commitment to research and development, Gi Innovation seeks to harness cutting-edge technology to solve complex challenges. The firm specializes in providing software and hardware solutions that are tailored to meet the specific needs of its clients. Driven by a team of experienced professionals, Gi Innovation aims to foster sustainable growth and innovation, ensuring that its products not only meet current market demands but also anticipate future trends. The company's approach is collaborative, working closely with stakeholders to deliver customized solutions that improve productivity and profitability.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

10 Patents

#344 in Seoul

#1,037 in South Korea

#54,443 in the World

Seoul, South Korea

Gi Innovation, Inc.

Forward Citations = 4

10 inventors:

Myung Ho Jang (7 out of 10 patents)

Young Jun Koh (4 out of 13 patents)

Su Youn Nam (3 out of 7 patents)

4. Myoung Ho Jang (3 out of 5 patents)

5. Zungyoon Yang (2 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…